Article
Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients.
The Journal of clinical endocrinology and metabolism - 1 Jun 2008
Soardi F C, Barbaro M, Lau I F, Lemos-Marini S H V, Baptista M T M, Guerra-Junior G, Wedell A, Lajic S, de Mello M P
Abstract excerpt
BACKGROUND: Most patients with 21-hydroxylase deficiency carry CYP21A1P-derived mutations, but an increasing number of novel and rare mutations have been reported in disease-causing alleles. OBJECTIVE: Functional effects of three novel (p.G56R, p.L107R, p.L142P) and one recurrent (p.R408C) CYP21A2 mutations were investigated. The degree of enzyme impairment caused by p.H62L alone or combined to p.P453S was also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
